KayLoni L Olson1, Rebecca H Neiberg2, Mark A Espeland2, Karen C Johnson3, William C Knowler4, Xavier Pi-Sunyer5,6, Amanda E Staiano7, Lynne E Wagenknecht8, Rena R Wing1. 1. Warren Alpert Medical School, Brown University, The Miriam Hospital, Providence, Rhode Island, USA. 2. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. 3. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA. 4. National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA. 5. Department of Medicine, New York Obesity Research Center, New York, New York, USA. 6. Institute of Human Nutrition, Columbia University, New York, New York, USA. 7. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA. 8. Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Abstract
OBJECTIVE: The Action for Health in Diabetes (Look AHEAD) trial was a randomized trial comparing effects of intensive lifestyle intervention (ILI) and diabetes support and education (DSE) on cardiovascular disease (CVD) among individuals with overweight/obesity and type 2 diabetes. A secondary analysis was conducted to evaluate the association between change in weight and waist circumference (WC) and CVD outcomes. METHODS: Participants (N = 5,490) were classified into four categories based on change in weight and WC between baseline and year 1 (both increased, both decreased, etc.). Separate Cox proportional hazards regression models were fit for ILI and DSE (using group that reduced weight/WC as reference), and time to first occurrence of primary and secondary CVD outcomes from year 1 through a median of almost 10 years were compared. Second, time to first event among all four ILI groups relative to DSE was evaluated. RESULTS: Within DSE, CVD outcomes did not differ. ILI participants with increased WC had increased risk of primary outcomes, regardless of weight loss (hazard ratio: 1.55 [95% CI: 1.11-2.17]) or weight gain (hazard ratio: 1.76 [95% CI: 1.07-2.89]), and had increased risk of secondary outcomes (overall P < 0.01) relative to ILI participants who reduced both weight and WC and relative to DSE participants. CONCLUSIONS: In this secondary analysis, increased WC during the first year of ILI, independent of weight change, was associated with higher risk for subsequent cardiovascular outcomes.
OBJECTIVE: The Action for Health in Diabetes (Look AHEAD) trial was a randomized trial comparing effects of intensive lifestyle intervention (ILI) and diabetes support and education (DSE) on cardiovascular disease (CVD) among individuals with overweight/obesity and type 2 diabetes. A secondary analysis was conducted to evaluate the association between change in weight and waist circumference (WC) and CVD outcomes. METHODS: Participants (N = 5,490) were classified into four categories based on change in weight and WC between baseline and year 1 (both increased, both decreased, etc.). Separate Cox proportional hazards regression models were fit for ILI and DSE (using group that reduced weight/WC as reference), and time to first occurrence of primary and secondary CVD outcomes from year 1 through a median of almost 10 years were compared. Second, time to first event among all four ILI groups relative to DSE was evaluated. RESULTS: Within DSE, CVD outcomes did not differ. ILI participants with increased WC had increased risk of primary outcomes, regardless of weight loss (hazard ratio: 1.55 [95% CI: 1.11-2.17]) or weight gain (hazard ratio: 1.76 [95% CI: 1.07-2.89]), and had increased risk of secondary outcomes (overall P < 0.01) relative to ILI participants who reduced both weight and WC and relative to DSE participants. CONCLUSIONS: In this secondary analysis, increased WC during the first year of ILI, independent of weight change, was associated with higher risk for subsequent cardiovascular outcomes.
Authors: Samuel Klein; David B Allison; Steven B Heymsfield; David E Kelley; Rudolph L Leibel; Cathy Nonas; Richard Kahn Journal: Obesity (Silver Spring) Date: 2007-05 Impact factor: 5.002
Authors: Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski Journal: N Engl J Med Date: 2013-06-24 Impact factor: 91.245
Authors: Aidin Rawshani; Araz Rawshani; Stefan Franzén; Naveed Sattar; Björn Eliasson; Ann-Marie Svensson; Björn Zethelius; Mervete Miftaraj; Darren K McGuire; Annika Rosengren; Soffia Gudbjörnsdottir Journal: N Engl J Med Date: 2018-08-16 Impact factor: 91.245
Authors: Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski Journal: Diabetes Care Date: 2007-03-15 Impact factor: 19.112
Authors: Robert Ross; Ian Janssen; Jody Dawson; Ann-Marie Kungl; Jennifer L Kuk; Suzy L Wong; Thanh-Binh Nguyen-Duy; SoJung Lee; Katherine Kilpatrick; Robert Hudson Journal: Obes Res Date: 2004-05
Authors: Rena R Wing; Wei Lang; Thomas A Wadden; Monika Safford; William C Knowler; Alain G Bertoni; James O Hill; Frederick L Brancati; Anne Peters; Lynne Wagenknecht Journal: Diabetes Care Date: 2011-05-18 Impact factor: 19.112
Authors: Edward Gregg; John Jakicic; George Blackburn; Paul Bloomquist; George Bray; Jeanne Clark; Mace Coday; Jeffrey Curtis; Caitlin Egan; Mary Evans; John Foreyt; Gary Foster; Helen Hazuda; James Hill; Edward Horton; Van Hubbard; Robert Jeffery; Karen Johnson; Abbas Kitabchi; William Knowler; Andrea Kriska; Wei Lang; Cora Lewis; Maria Montez; David Nathan; Rebecca Neiberg; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; Bruce Redmon; Judith Regensteiner; Jack Rejeski; Paul Ribisl; Monika Safford; Kerry Stewart; Dace Trence; Thomas Wadden; Rena Wing; Susan Yanovski Journal: Lancet Diabetes Endocrinol Date: 2016-08-30 Impact factor: 32.069
Authors: Robert Ross; Ian J Neeland; Shizuya Yamashita; Iris Shai; Jaap Seidell; Paolo Magni; Raul D Santos; Benoit Arsenault; Ada Cuevas; Frank B Hu; Bruce A Griffin; Alberto Zambon; Philip Barter; Jean-Charles Fruchart; Robert H Eckel; Yuji Matsuzawa; Jean-Pierre Després Journal: Nat Rev Endocrinol Date: 2020-02-04 Impact factor: 43.330
Authors: Jeanne M McCaffery; Kathleen A Jablonski; Qing Pan; Arne Astrup; Malene Revsbech Christiansen; Dolores Corella; Lauren M L Corso; Jose C Florez; Paul W Franks; Christopher Gardner; Torben Hansen; Tuomas O Kilpeläinen; William C Knowler; Jaana Lindström; Wim H M Saris; Thorkild I A Sørensen; Jaakko Tuomilehto; Matti Uusitupa; Rena R Wing; Tanya Agurs-Collins Journal: Diabetes Date: 2022-04-01 Impact factor: 9.337
Authors: Noel P T Chan; Agnes Y K Lai; Hau K Choy; Derek Y T Cheung; Alice N T Wan; Victor Y H Cheng; Ka Y Chan; Yuk K Lau; Chi Y Yung; George O C Cheung; T H Lam Journal: Front Public Health Date: 2022-07-14